Literature DB >> 21955043

Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort.

William S Oetting1, David P Schladt, Robert E Leduc, Pamala A Jacobson, Weihua Guan, Arthur J Matas, Ajay Israni.   

Abstract

There have been numerous reports proposing a statistically significant association between a genetic variant, usually in the form of a single nucleotide polymorphism (SNP), and acute rejection (AR). Unfortunately, there are additional publications reporting a lack of association with AR when a different cohort of recipients was analyzed for the same SNP. The objective of this report was to attempt replication of these published finding in our own kidney allograft recipient cohort. We analyzed 23 genetic variants, previously reported to have a significant association with AR, using a cohort of 969 clinically well-defined kidney transplant recipients. Only one SNP, rs6025 (Leiden mutation), within the coagulation factor V gene, showed a significant association with a P-value of 0.011 in a race-adjusted analysis and a P-value of 0.0003 in multiple variable analysis. An additional SNP, rs11706052 in IMPDH2, gave a modest P-value of 0.044 using multiple variable analysis, which is not significant when multiple testing is taken into consideration. Our results suggest that careful validation of previously reported associations with AR is necessary, and different strategies other than candidate gene studies can help to identify causative genetic variants associated with AR.
© 2011 The Authors. Transplant International © 2011 European Society for Organ Transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955043      PMCID: PMC3208796          DOI: 10.1111/j.1432-2277.2011.01359.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  40 in total

1.  Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates.

Authors:  F Y Hsieh; P W Lavori
Journal:  Control Clin Trials       Date:  2000-12

2.  Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection.

Authors:  H Ekberg; P J Svensson; M Simanaitis; B Dahlbäck
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

3.  IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection.

Authors:  A Pawlik; L Domanski; J Rozanski; M Florczak; E Dabrowska-Zamojcin; G Dutkiewicz; B Gawronska-Szklarz
Journal:  Transplant Proc       Date:  2005-06       Impact factor: 1.066

Review 4.  The impact of immune gene polymorphisms in kidney and liver transplantation.

Authors:  Peter Nickerson
Journal:  Clin Lab Med       Date:  2008-09       Impact factor: 1.935

5.  Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection.

Authors:  Majid Shahbazi; Anthony A Fryer; Vera Pravica; Iain J Brogan; Helen M Ramsay; Ian V Hutchinson; Paul N Harden
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

6.  Association of G-137C IL-18 promoter polymorphism with acute allograft rejection in renal transplant recipients.

Authors:  Chan-Duck Kim; Hye-Myung Ryu; Ji-Young Choi; Hee-Jeong Choi; Hyuk-Joon Choi; Ji-Hyung Cho; Sun-Hee Park; Dong-Il Won; Yong-Lim Kim
Journal:  Transplantation       Date:  2008-12-15       Impact factor: 4.939

7.  Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.

Authors:  Lina Quteineh; Céline Verstuyft; Valerie Furlan; Antoine Durrbach; Alexia Letierce; Sophie Ferlicot; Anne-Marie Taburet; Bernard Charpentier; Laurent Becquemont
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-12       Impact factor: 4.080

8.  TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.

Authors:  J-Y Park; M H Park; H Park; J Ha; S J Kim; C Ahn
Journal:  Tissue Antigens       Date:  2004-12

9.  Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.

Authors:  Brian Van Ness; Christine Ramos; Majda Haznadar; Antje Hoering; Jeff Haessler; John Crowley; Susanna Jacobus; Martin Oken; Vincent Rajkumar; Philip Greipp; Bart Barlogie; Brian Durie; Michael Katz; Gowtham Atluri; Gang Fang; Rohit Gupta; Michael Steinbach; Vipin Kumar; Richard Mushlin; David Johnson; Gareth Morgan
Journal:  BMC Med       Date:  2008-09-08       Impact factor: 8.775

10.  Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.

Authors:  S W Kang; S J Park; Y W Kim; Y H Kim; H S Sohn; Y C Yoon; H Joo; K H Jeong; S H Lee; T W Lee; C G Ihm
Journal:  Int J Immunogenet       Date:  2008-02       Impact factor: 1.466

View more
  13 in total

1.  Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

Authors:  William S Oetting; David P Schladt; Casey R Dorr; Baolin Wu; Weihua Guan; Rory P Remmel; David Iklé; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

2.  Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients.

Authors:  Jeannine S McCune; Barry Storer; Sushma Thomas; Jožefa McKiernan; Rohan Gupta; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-12       Impact factor: 5.742

3.  Moving Beyond Minimization Trials in Kidney Transplantation.

Authors:  Arthur J Matas; Robert S Gaston
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

Review 4.  Transplant genetics and genomics.

Authors:  Joshua Y C Yang; Minnie M Sarwal
Journal:  Nat Rev Genet       Date:  2017-03-13       Impact factor: 53.242

Review 5.  Biomarkers and Pharmacogenomics in Kidney Transplantation.

Authors:  L E Crowley; M Mekki; S Chand
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

6.  Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children.

Authors:  Pauline Lancia; Beate Aurich; Phuong Ha; Anne Maisin; Véronique Baudouin; Evelyne Jacqz-Aigrain
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

Review 7.  Genetics of acute rejection after kidney transplantation.

Authors:  Casey R Dorr; William S Oetting; Pamala A Jacobson; Ajay K Israni
Journal:  Transpl Int       Date:  2017-11-08       Impact factor: 3.782

8.  Transplant rejection and risk: in search of the genetic dark matter.

Authors:  William S Oetting; Pamela A Jacobson; Ajay K Israni
Journal:  J Gastrointestin Liver Dis       Date:  2013-06       Impact factor: 2.008

9.  Genetic determinants of renal transplant outcome: where do we stand?

Authors:  Paul J Phelan; Peter J Conlon; Matthew A Sparks
Journal:  J Nephrol       Date:  2014-02-11       Impact factor: 3.902

Review 10.  The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

Authors:  Dennis A Hesselink; Rachida Bouamar; Laure Elens; Ron H N van Schaik; Teun van Gelder
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.